Navigation Links
New HAE Drug Candidate from Dyax Produced by Laureate Biopharma
Date:8/26/2013

or more than 30 years, including IgG, IgM, fragmented (Fab & F(ab')2), conjugated, aglycosylated and domain-deleted antibodies."

About Laureate Biopharmaceutical Services, Inc.
Laureate Biopharmaceutical Services, Inc. is a full-service biopharmaceutical contract development and manufacturing organization. Laureate Biopharma's scientists are expert in process development and cGMP production of therapeutic proteins including monoclonal antibodies and Fc-fusion proteins. In addition, the company's portfolio of services includes aseptic filling, cell line development, analytical and stability testing, and regulatory support. Laureate Biopharma has served a global client base from its Princeton, New Jersey facility since 1981 and is a portfolio company of Saints Capital, LLC.  For more information, please visit www.LBioS.com.

About Dyax
Dyax is a fully integrated biopharmaceutical company focused on the discovery, development and commercialization of novel biotherapeutics for unmet medical needs.  The Company's key value drivers are the KALBITOR® (ecallantide) business, DX-2930 and the Licensing and Funded Research Program (LFRP).

For additional information about Dyax, please visit www.dyax.com.

For additional information about KALBITOR, including full prescribing information, please visit www.KALBITOR.com.

For more information, contact: Michiel E. Ultee, Ph.D., Chief Scientific Officer, Laureate Biopharma, at (609) 919-3390 or info@LBioS.com, or visit www.LBioS.com.


'/>"/>
SOURCE Laureate Biopharma
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Alder BioPharmaceuticals Inc. Initiates Phase 1 Clinical Study of Antibody Therapeutic Candidate for Treatment of Migraine, ALD403
2. Rigel Advances Asthma Programs: Two Inhaled Drug Candidates Take Aim at Acute and Chronic Lung Disease
3. Xiangxue Pharmaceuticals to Acquire Rights for a Promising Drug Candidate from Kinex Pharmaceuticals for the Greater China Territory
4. Lilly Diabetes Presents Phase II Blood Pressure and Heart Rate Data on Investigational GLP-1 Analog Candidate, Dulaglutide, in Patients with Type 2 Diabetes at the 27th American Society of Hypertension Scientific Meeting
5. Marshall Edwards Announces First Cohort Of Patients Dosed In Phase I Clinical Trial Of Oncology Drug Candidate ME-344
6. Flexions Lead Osteoarthritis Drug Candidate Demonstrates Significant, Prolonged Improvement in Pain and Function in Phase 2 Trial
7. Polaris Group Lead Therapeutic Candidate ADI-PEG 20 Demonstrates Potential Anticancer Activity in Various Metastatic Sarcomas and Bladder Cancers That Are Deficient in Key Metabolic Protein, and Enhanced Effects with Combination Therapy in Melanoma
8. New Candidate Drug Stops Cancer Cells, Regenerates Nerve Cells
9. Chimerix Signs Worldwide License Agreement With Merck For CMX157, A Novel Candidate For The Treatment Of HIV
10. Test Results Show Unprecedented Achievement for Marburg Drug Candidate
11. As Tuberculosis Grows More Difficult to Control, Vaccine Candidate to Prevent Disease Enters Clinical Testing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... Research and Markets has announced the addition ... Pharmaceutical Equipment Market in China, 2014-2018" report to ... Forecast of Pharmaceutical Equipment Market in China ... pharmaceutical equipment industry in the aspects of current ... performance of domestic major enterprises, as well as offers ...
(Date:8/29/2014)... 2014 According to the ... Services (Equipment, Reagent, Primer, Probe, Custom Oligos), End-User ... Gene Synthesis, NGS, DNA, RNAi) - Global Forecast ... Synthesis Market is expected to reach $1,712.1 Million ... at a CAGR of 9.8% from 2014 to ...
(Date:8/29/2014)... , Aug. 29, 2014 /PRNewswire-iReach/ -- ChemImage will ... the Australian and New Zealand Forensic Science Society,s ... Sciences in Adelaide, Australia . ... concerning the advancements that hyperspectral imaging can bring ... Jeffrey Beckstead , Director of Product Development at ...
Breaking Medicine Technology:Research and Development Trend Forecast of Pharmaceutical Equipment Market in China, 2014-2018 2Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 2Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 3Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 4ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 2ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 3
(Date:8/30/2014)... August 30, 2014 Patients suffering from ... disorder in a new review published by Daily Gossip. ... deal with, so there is no wonder that numerous ... The Natural Vitiligo Treatment is one of the most ... Vitiligo Treatment promises to stop the spread of this ...
(Date:8/30/2014)... August 30, 2014 The term ... and Pharameuticals. Nutraceuticals is a source of healthy-dietary ... from natural food sources. Nutraceutical ingredients have certain ... the human body. Nutraceutical health products include factors ... foods and more. Although nature is the most ...
(Date:8/30/2014)... Acne is a common problem millions of American cope with every ... daily nuisance, for some, it can have a crippling impact on ... to dramatic mood swings and depression. , Those struggling with ... skin. In some cases, that can make the problem even worse. ... on a quest for clearer skin can now view acne ...
(Date:8/30/2014)... August 30, 2014 Continuing to meet ... is expanding with the addition of a new doctor ... who has provided leading-edge skin care in Grand Rapids ... , “As a doctor, my passion is making ... partnering with Forefront Dermatology, I’m better able to focus ...
(Date:8/30/2014)... used to treat gout, before and after cardiac ... from this type of surgery, but it did ... to a study published by JAMA . ... coincide with its presentation at the European Society ... surgery include postpericardiotomy syndrome (the occurrence of the ...
Breaking Medicine News(10 mins):Health News:Natural Vitiligo Treatment Review Exposes Fast Method for Skin Repigmentation 2Health News:A Granular Analysis of the Nutraceutical Ingredients Market by Transparency Market Research 2Health News:A Granular Analysis of the Nutraceutical Ingredients Market by Transparency Market Research 3Health News:A Granular Analysis of the Nutraceutical Ingredients Market by Transparency Market Research 4Health News:Acne Treatment Reviews Added to Popular Treatment Website 2Health News:Expanding Care at the Forefront of Dermatology 2Health News:Medication shows mixed results in reducing complications from cardiac surgery 2
... Kaiser Permanente,s Commitment to Buying Green, OAKLAND, ... and the Green Electronics Council today,recognized Kaiser Permanente ... buying environmentally friendly computers. Kaiser Permanente,was the only ... "Going,Green" when buying electronic products. The EPA, ...
... 2 Smooth talking Mitt,Romney is back in Boston ... hypocrisy on the campaign trail. Asked by a reporter ... provide health insurance to 3.8 million,uninsured children by expanding ... has vowed to do, Romney said "Yeah.,Yeah, I sure ...
... It is the world,s smallest and first,true pocket-ultrasound ... only 1.6 pounds, the ACUSON P10 fits into a ... used by physicians in places,like the Intensive Care Unit, ... Siemens (NYSE: SI ) at:, http://media.medialink.com/WebNR.aspx?story=33909 ) ...
... against Human Papilloma Virus (HPV) - the first adolescent ... discussed at the National Cancer Research Institute conference in ... Kitchener, of The University of Manchester, will chair the ... , His colleague Dr Loretta Brabin, who is leading ...
... 2007 For the first time, data show a ... infants overall health at birth. Babies born to women ... appear to be less likely to need intensive care ... Laboratories, Inc. (NASDAQ:CBRX) announced today. The data are published ...
... receive the lifesaving devices, studies find , , TUESDAY, Oct. ... men to receive implantable defibrillators, and black patients are ... heart devices. , Two studies documenting these findings echo ... made in this area of inequity. , "In the ...
Cached Medicine News:Health News:Kaiser Permanente Named Green Electronics Champion by EPA, Green Electronics Council 2Health News:Kaiser Permanente Named Green Electronics Champion by EPA, Green Electronics Council 3Health News:DNC: Romney Chooses President Bush Over Uninsured Children 2Health News:DNC: Romney Chooses President Bush Over Uninsured Children 3Health News:Vaginal progesterone gel may improve infant outcomes and... 2Health News:Vaginal progesterone gel may improve infant outcomes and... 3Health News:Vaginal progesterone gel may improve infant outcomes and... 4Health News:Women Less Likely to Get Heart Defibrillators 2Health News:Women Less Likely to Get Heart Defibrillators 3
... of flexible lighting products. The first is ... different sizes 5", 10", and 15" (refers ... light). These lights are for use in ... ,The second group of flexible lights is ...
These units, though small, still offer sufficient output to ensure current is fully adjustable from 0 to 70 mA. Instruction manual, ball electrodes, battery and leads with alligator clips are include...
... Aaron manufactures two groups of flexible lighting ... and non-sterile in three different sizes 5", ... shaft portion of the light). These lights ... light is needed., ,The second group ...
Designed to be used for neuromuscular blockage monitoring. Provides for easy placement over the ulnar nerve on a patient's wrist. Dual element permits non-invasive monitoring using a single electrode...
Medicine Products: